Receptor News and Research

RSS

Research reveals why patients with diabetes have poorer prognosis for prostate cancer

Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.

31 Jan 2018

Neuroscientist wins NIH grant to find whether pear- or apple-shape physique is best for our brains

With the new year still ringing, many of us have fat on our minds, but Dr. Alexis M. Stranahan is more interested in what fat does to our minds.

29 Jan 2018

Blood pressure and cholesterol lowering drugs do not negatively affect erectile function, study says

New study provides reassurance for men taking blood pressure and cholesterol modifying medications, reports the Canadian Journal of Cardiology.

29 Jan 2018

Researchers reveal important role of estrogen in neuroblastoma

The female sex hormone estrogen can perform an important role in neuroblastoma, a form of cancer mainly affecting young children.

29 Jan 2018

FDA approves new radioactive drug for treatment of rare digestive tract cancers

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

29 Jan 2018

Study reveals existence of previously unknown immune defense mechanisms in bacteria

Until a decade ago, scientists were not aware that bacteria had complex immune systems – ones that could keep up with the pace of evolution in viruses called phages that infect bacteria.

27 Jan 2018

High levels of body fat in women with normal BMI linked to increased breast cancer risk

Among postmenopausal women with normal body mass index, those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.

27 Jan 2018

Scientists test new tactic for controlling motor complications in Parkinson's disease

Standard drug treatment for Parkinson's disease can over time induce motor complications that reduce the effectiveness of restoring mobility.

27 Jan 2018

UTokyo enters into agreement for developing personalized cancer vaccine

The University of Tokyo entered an agreement for developing a personalized cancer vaccine using a novel method involving the body's immune response.

25 Jan 2018

UK-based charity to accelerate development of promising new drug for Parkinson's

UK-based charity, Parkinson's UK is set to provide more than $1million in funding to US biotech company, Neurolixis, to accelerate the development of a promising new drug for people with Parkinson's.

24 Jan 2018

Scientists discover new target for anti-angiogenic tumor therapy

Actively growing tumors have a high demand for oxygen and nutrients. Therefore, they stimulate the growth of blood vessels.

23 Jan 2018

Metabolic shift can result in congestive heart failure

The heart derives its energy primarily from fatty acids. However, if a metabolic shift to other energy sources takes place, this can result in congestive heart failure, scientists from the German Cancer Research Center and Heidelberg University Hospital have now discovered.

23 Jan 2018

New discovery sheds light on iron-restricted anemia that causes fatigue in millions

A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells.

22 Jan 2018

Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases

An international team of researchers led by prof. Savvas Savvides has unraveled a crucial aspect of the molecular basis of autoimmune and inflammatory diseases such as psoriasis, rheumatoid arthritis and Crohn's disease.

18 Jan 2018

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes skin inflammation in atopic dermatitis and the characteristic thickening of the skin.

18 Jan 2018

Receptor News and Research

Research reveals why patients with diabetes have poorer prognosis for prostate cancer

Neuroscientist wins NIH grant to find whether pear- or apple-shape physique is best for our brains

Blood pressure and cholesterol lowering drugs do not negatively affect erectile function, study says

Researchers reveal important role of estrogen in neuroblastoma

FDA approves new radioactive drug for treatment of rare digestive tract cancers

Study reveals existence of previously unknown immune defense mechanisms in bacteria

High levels of body fat in women with normal BMI linked to increased breast cancer risk

Scientists test new tactic for controlling motor complications in Parkinson's disease

UTokyo enters into agreement for developing personalized cancer vaccine

UK-based charity to accelerate development of promising new drug for Parkinson's

Scientists discover new target for anti-angiogenic tumor therapy

Metabolic shift can result in congestive heart failure

New discovery sheds light on iron-restricted anemia that causes fatigue in millions

Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

Study identifies new target for treatment of depression

Bile acids: A new therapy against obesity

Researchers identify new anti-inflammatory drug target

Bile acids could directly burn away lipids in the fat depots

Penn scientists identify new therapeutic target for treatment of melanoma

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News